All stock lists
Unlock the score
Alphatec Holdings, Inc. (NASDAQ:ATEC)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
10.94-0.17 (-1.53%)
Market cap
$1.69B
Insider Score
Health Score
Analyst consensus
Listed since
Jun 1, 2006
Website
Insider Score
/ 100
ATEC Insider Score
Alphatec Holdings, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
Financial Health Score
Fair
From ATEC’s reported statements · Q2 2026 (trailing 12 months)
Profitability3 / 20
Loses money on what it sells.
- Revenue
- $815.1M
- Net income
- -$110.0M
- Net margin
- -13.5%
Leverage0 / 20
Heavily indebted for what it earns.
- Total debt
- $604.0M
- Cash
- $118.7M
- Net debt / EBITDA
- 36.07x
Liquidity18 / 20
Comfortably covers what is due within a year.
- Current assets
- $449.0M
- Current liabilities
- $238.0M
- Current ratio
- 1.89
Cash generation12 / 20
Roughly cash-neutral.
- Operating cash flow
- $56.5M
- Free cash flow
- $4.2M
- FCF margin
- 0.5%
Dilution & runway17 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 155.3M
- Share growth (1y)
- 3.6%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
ATEC Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 213.51 M | 192.11 M | 212.93 M | 196.50 M | 185.54 M | 169.18 M |
| Revenue Growth (YoY) | 15.07 % | 13.55 % | 20.44 % | 30.38 % | 27.46 % | 22.17 % |
| Cost of Revenue | 59.41 M | 74.77 M | 82.54 M | 59.20 M | 56.44 M | 53.18 M |
| Gross Profit | 154.10 M | 117.34 M | 130.39 M | 137.30 M | 129.10 M | 116.00 M |
| SG&A Expense | 134.00 M | 137.06 M | 113.47 M | 124.30 M | 118.51 M | 127.02 M |
| R&D Expense | 18.17 M | 17.56 M | 22.73 M | 18.68 M | 18.28 M | 16.58 M |
| Operating Expenses | 156.01 M | 139.40 M | 135.75 M | 153.23 M | 142.19 M | 160.29 M |
| Operating Income | -1.91 M | -22.06 M | -5.36 M | -15.93 M | -13.09 M | -44.29 M |
| Pretax Income | -25.63 M | -33.86 M | -21.75 M | -28.50 M | -41.18 M | -51.97 M |
| Tax Provision | 156.00 K | 50.00 K | -18.00 K | 74.00 K | -37.00 K | -64.00 K |
| Net Income | -25.78 M | -33.91 M | -21.73 M | -28.58 M | -41.14 M | -51.91 M |
| EPS (Basic) | -0.16 | -0.22 | -0.15 | -0.19 | -0.27 | -0.35 |
| EPS (Diluted) | -0.16 | -0.22 | -0.15 | -0.19 | -0.27 | -0.35 |
| Shares Outstanding | 155.33 M | 154.05 M | 150.06 M | 151.40 M | 149.91 M | 146.73 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.